MST1 and diabetes mellitus: Our results not only proved that asialo-rhuEPOP is cytoprotective toward beta-cells but also revealed that it can also suppress activation of MST1, a key player that determines the susceptibility of beta-cells to apoptosis and ultimately leading to diabetes.